1. Introduction {#sec1-metabolites-09-00192}
===============

Vitamin B~12~ (B~12~), commonly known as the red-colored vitamin, has the largest molecular mass and the most complex structure of all vitamins. B~12~ is only synthesized by certain bacteria and is primarily concentrated in higher predatory organisms in the food chain. Thus, animal-derived foods such as meat, milk, and fish are good sources of B~12~ \[[@B1-metabolites-09-00192]\]. Plant-derived foods such as vegetables and fruits contain no or trace amounts of B~12~ because plants do not require B~12~ for growth. Therefore, strict vegetarians are at a greater risk of developing B~12~ deficiency than nonvegetarians \[[@B2-metabolites-09-00192]\]. People with atrophic gastritis who develop low stomach acid output easily present the food protein--bound B~12~ malabsorption, which prevails in elderly people. Thus, strict vegetarians and elderly people are at an increased risk of developing B~12~ deficiency. In case of hereditary B~12~ deficiency, the patients defect transport proteins (intrinsic factor, a transcobalamin II, and R-binder) and the factors regarding the intracellular processing of B~12~ participating in absorption, blood transport, and intracellular metabolism of B~12~ \[[@B3-metabolites-09-00192]\].

B~12~ is converted into two coenzyme forms in living cells, namely, 5′-deoxyadenosylcobalamin and methylcobalamin, which function as coenzymes for methylmalonyl-CoA mutase (MCM, EC 5.4.99.2) \[[@B4-metabolites-09-00192]\] and methionine synthase (MS, EC 2.1.1.13) \[[@B5-metabolites-09-00192]\], respectively. MCM catalyzes the conversion of *R*-methylmalonyl-CoA to succinyl-CoA via the tricarboxylic acid (TCA) cycle in the catabolic pathways of branched-chain amino acids (valine, leucine, and isoleucine) and methionine. B~12~ deficiency leads to the excess accumulation of methylmalonic acid (MMA), which potently inhibits succinate dehydrogenase in the TCA and further leads to the disruption of normal glucose and glutamic acid metabolism \[[@B6-metabolites-09-00192]\]. MS is involved in the synthesis of methionine from homocysteine and N^5′^-methyltetrahydrofolate, and the formed methionine is converted to *S*-adenosylmethionine (SAM), which is involved in cellular methylation reactions \[[@B7-metabolites-09-00192]\]. In addition, B~12~ deficiency reportedly results in significant increases in homocysteine, which induces oxidative damage in various cellular components. Accordingly, B~12~ deficiency can induce various diseases, such as megaloblastic anemia, developmental disorders, growth retardation, and neuropathy. However, the mechanisms involved remain poorly understood.

Results from our previous study indicated that *Caenorhabditis elegans* developed severe B~12~ deficiency associated with infertility, growth retardation, and reduced lifespan when grown under B~12~-deficient conditions \[[@B8-metabolites-09-00192]\], suggesting that *C. elegans* may be a suitable model for understanding the physiological function of B~12~ and the mechanisms underlying the symptoms caused by B~12~ deficiency.

As described above, both B~12~-dependent MCM and MS function in the cellular metabolism of various amino acids. Indeed, B~12~ deficiency reportedly induces disorders of various amino acids metabolized in the B~12~-dependent pathway and indirectly affects amino acids metabolized in B~12~-independent pathways \[[@B9-metabolites-09-00192]\]. However, there is limited information available regarding whether such amino acid disorders induce these symptoms of B~12~ deficiency.

In this study, we determined free amino acid levels in B~12~-deficient *C. elegans* for clarifying the mechanisms underlying the symptoms caused by B~12~ deficiency. Therefore, ornithine was significantly increased in *C. elegans* during B~12~ deficiency. Ornithine, a precursor compound of polyamines, is formed from arginine as an essential amino acid in worms \[[@B10-metabolites-09-00192]\]. While this process is catalyzed by arginase, *C. elegans* do not contain an intact urea cycle because no homologous genes involved in the urea cycle have been found (wormbase, wormbase.org, KEGG, and <https://www.genome.jp/kegg/>). However, in this study, we demonstrated that B~12~ deficiency significantly increased arginase activity, leading to increased ornithine. Furthermore, the synthesis of spermidine from ornithine was significantly decreased during B~12~ deficiency, which appears to be an important factor responsible for the reduced lifespan of B~12~-deficient worms.

2. Materials and Methods {#sec2-metabolites-09-00192}
========================

2.1. Organisms {#sec2dot1-metabolites-09-00192}
--------------

The N2 Bristol wild-type *C. elegans* strain was maintained at 20 °C on nematode growth medium plates using the *Escherichia coli* OP50 strain as a food source \[[@B11-metabolites-09-00192]\]. B~12~-supplemented (control) and B~12~-deficient worms were prepared as described previously \[[@B8-metabolites-09-00192]\]. B~12~-deficient worms were then transferred to B~12~-supplemented medium for three generations and used as the recovery worms \[[@B8-metabolites-09-00192]\]. For evaluating the effects of B~12~ deficiency on polyamine levels and the lifespan of the worms, we prepared control worms are grown in ornithine-supplemented (final concentration 10 μmol/L) medium for three days and B~12~-deficient worms grown in SAM-supplemented (final concentration 1 μmol/L) medium for three days.

2.2. Preparation of a Homogenate of Worms {#sec2dot2-metabolites-09-00192}
-----------------------------------------

Control, B~12~-deficient, and recovery worms (0.2 g wet weight each) were homogenized in 500 μL of 100 mmol/L potassium phosphate buffer (pH 7.0) on ice using a hand homogenizer (AS ONE Corp., Osaka, Japan). The homogenates were centrifuged at 15,000× *g* for 10 min at 4 °C, and these supernatants were used as crude enzymes or crude homogenates, except where otherwise noted.

2.3. Determination of Free Amino Acids in Worm Bodies {#sec2dot3-metabolites-09-00192}
-----------------------------------------------------

The homogenates of worms as described above were heated at 80 °C for 10 min and then centrifuged at 15,000× *g* for 10 min at 4 °C, the supernatants (200 μL each) were added to 100 μL of 10% (*v*/*v*) trichloroacetic acid, mixed vigorously, and centrifuged at 10,000× *g* for 10 min at 4 °C. Each supernatant (250 μL) was diluted with an equal volume of 0.25 mol/L lithium citrate buffer (pH 2.2) (Wako Pure Chemical Industries, Osaka, Japan). The diluted solution, after being filtered with Millex^®^-LH membrane filter (Merck Millipore, Darmstadt, Germany), was analyzed using a fully-automated amino acid analyzer (JEOL JLC-500/V, Nihon Denshi, Tokyo, Japan). The injection volume was 50 μL. [Figure 1](#metabolites-09-00192-f001){ref-type="fig"} indicates the outlines of the free amino acid analysis method. [Supplementary Figure S1](#app1-metabolites-09-00192){ref-type="app"} shows the chromatograms of free amino acid analysis.

2.4. Enzyme Assays {#sec2dot4-metabolites-09-00192}
------------------

Ornithine decarboxylase (ODC) activity was assayed using high-performance liquid chromatography (HPLC) using a fluorescence derivatization method of putrescine (Put) \[[@B12-metabolites-09-00192]\]. In detail, worms (0.05 g) grown under control, B~12~ deficiency, recovery, ornithine-supplemented control, and SAM-supplemented B~12~ deficiency conditions were homogenized in a 40 mmol/L sodium phosphate buffer (pH 7.5) (200 μL) containing 0.1 mmol/L pyridoxal phosphate and 2 mmol/L dithiothreitol and centrifuged at 15,000× *g* for 10 min at 4 °C. The supernatant fraction was then used as the crude enzyme. The reaction mixture (250 μL) contained 50 mmol/L sodium phosphate buffer (pH 7.5), 0.15 mmol/L pyridoxal phosphate, 0.3 mmol/L L-ornithine, and 100 μL of each crude enzyme. The enzymatic reaction was started with the addition of L-ornithine, incubated for an hour at 37 °C, and terminated with the addition of 50 μL of 8% (*v*/*v*) HClO~4~. The reaction mixture was then centrifuged at 15,000× *g* for 10 min at 4 °C, and the supernatant was filtered with a Millex-LH membrane filter (Merck Millipore). An aliquot (30 μL) of the filtrate was treated with 30 μL of 50 μg/mL phthaldialdehyde regent (Sigma-Aldrich, Saint Louis, MO, USA) and 50 μL of 10 mmol/L borate buffer (pH 9.5) and then incubated for 4 min at 25 °C to form a fluorescent derivative of putrescine (Put). The prepared sample (20 μL) was then injected into a reverse-phase HPLC column (Wakosil-II 5C18HG, φ4.6 × 250 mm) that had been equilibrated with 80% methanol for 1 h at 25 °C. Put was eluted with a linear gradient of methanol 80% (*v*/*v*) to 100% (*v*/*v*) at 0--11 min, 100% (*v*/*v*) at 11--14 min, 100% (*v*/*v*) to 80% (*v*/*v*) at 14--15 min, and 80% (*v*/*v*) 15--20 min) at a flow rate of 1 mL/min at 25 °C. The fluorescent derivative was then determined with fixed excitation (340 nm) and emission (455 nm) wavelengths using a Shimadzu HPLC apparatus (SCL-10A VP system controller, DGU-20A3 degassing unit, LC-10Ai liquid chromatograph, and CTO-6A column oven) equipped with a fluorescence detector (RF-530, Shimadzu).

Arginase activity was assayed using an arginase assay kit (BioAssay Systems, CA, USA) according to the manufacturer's instructions. The absorbance at 430 nm that was changed by the enzyme reaction for 2 h was measured using a Sunrise Rainbow RC-R microplate reader (Tecan Austria GmbH, Salzburg, Austria). Arginase activity was then calculated with the calibration curve of urea as a standard. To obtain the optimum pH of worm arginase activity, various buffers ranging from pH 4.0 to 10.0 (pH 4--6, 20 mmol/L acetate-sodium acetate buffer, pH 6--8 20 mmol/L phosphate-sodium buffer, and pH 8--10 carbonate-sodium carbonate buffer) were used. Preliminary experiments indicated that the optimum temperature and pH of worm arginase was 30 °C and pH 8.0, respectively, and MnSO~4~ was required for enzyme activity ([Supplementary Figure S2](#app1-metabolites-09-00192){ref-type="app"}).

Regarding N^ω^-hydroxy-L-arginine (NOHA) as a specific arginase inhibitor, B~12~-deficient worms were grown in B~12~-deficient medium containing NOHA (final concentration at 10 nM) for 3 days before the assay of arginase activity assay. The arginase inhibitor was used at a concentration shown to not influence the growth of the worms.

2.5. Other Assays {#sec2dot5-metabolites-09-00192}
-----------------

SAM and *S*-adenosylhomocysteine (SAH) were assayed by HPLC according to the modified method of Wang et al. \[[@B13-metabolites-09-00192]\]. Each worm (0.05 g wet weight) was homogenized in 200 μL of 0.4 mol/L HClO~4~ on ice. After centrifugation at 15,000× *g* for 15 min at 4 °C, the supernatant was filtered through a Millex-LH membrane filter (Merck Millipore). Each prepared extract (20 μL) was injected into the Shimadzu HPLC apparatus equipped with an SPD-10A VP UV/VIS detector (Shimadzu). The analytical method was developed with a flow rate of 1 mL/min, column temperature of 35 °C, and UV detection at 254 nm. A Wakosil 5C18HG column (φ4.6 × 250 mm, Wako) was equilibrated with 80% solvent A (50 mmol/L NaH~2~PO~4~ (pH 3.0) containing 8 mmol/L octanesulfonic acid sodium salt) and 20% solvent B (methanol). SAM and SAH were eluted over a 13-min gradient as follows: 80% solvent A-20% solvent B at 0 min to 3 min, a liner gradient of 60% solvent A-40% solvent B at 3 min to 9 min, and 60% solvent A-40% solvent B at 9 min to 13 min. As modification points, column and gradient conditions were changed as described above.

Polyamines, such as Put and Spermidine (Spd), were analyzed using a standard HPLC method \[[@B14-metabolites-09-00192]\]. Worms (0.05 g wet weight) grown under control, B~12~ deficiency, recovery, ornithine-supplemented control, and SAM-supplemented B~12~ deficiency conditions were homogenized in 200 μL of 0.3 mol/L HClO~4~ using a hand homogenizer on ice. After centrifugation (15,000× *g*, 10 min at 4 °C), the supernatants were used as extracts. Polyamines were derivatized with benzoyl chloride, and the reaction mixture (1110 μL) was mixed with 1 mL of 2 mol/L NaOH, 10 μL of benzoyl chloride, and 100 μL of extract and incubated for 40 min at room temperature (25 °C). The reaction was terminated with the addition of 2 mL of a saturated NaCl solution, and benzoylated polyamines were extracted with 2 mL of cold diethyl ether. After centrifugation (1500× *g*, 5 min at 4 °C), an aliquot (1 mL) of diethyl ether was recovered, evaporated to dryness under a nitrogen flow, and dissolved in 200 μL of 50% (*v*/*v*) methanol. Authentic Put, Spd, and 1,6-diaminohexane were treated under the same conditions, and 1,6-diaminohexane was used as the internal standard. Each prepared extract was then filtered through a Millex-LH membrane filter (Merck Millipore) and injected into the Shimadzu HPLC apparatus equipped with a UV/VIS detector (Shimadzu). The analytical method was developed with a flow rate of 1 mL/min, column temperature of 35 °C, and UV detection at 254 nm. A Wakosil-II 5C18HG column (φ4.6 × 250 mm, Wako) was equilibrated with 50% methanol. Polyamines were eluted with a linear gradient of methanol 50% (*v*/*v*) to 55% (*v*/*v*) at 0--5 min, 55% (*v/v*) to 60% (*v*/*v*) at 5--20 min, and 60% (*v*/*v*) to 80% (*v*/*v*) at 20--25 min. [Figure 2](#metabolites-09-00192-f002){ref-type="fig"} shows the scheme of derivatization reaction of polyamines. [Supplementary Figure S3](#app1-metabolites-09-00192){ref-type="app"} showed the chromatograms of polyamine analysis.

2.6. Quantitative PCR Analysis {#sec2dot6-metabolites-09-00192}
------------------------------

Control worms were grown in ornithine (final concentration 10 μM)-supplemented control medium for three days to evaluate the effects of accumulated ornithine on worm polyamine metabolism. B~12~-deficient worms were grown in SAM (final concentration 1 μM)-supplemented B~12~-deficient medium for three days to clarify the effects of added SAM on worm polyamine metabolism. Control worms, ornithine-supplemented control worms, B~12~-deficient worms, and SAM-supplemented B~12~-deficient worms were used as samples in the following quantitative PCR analysis.

Total RNA was prepared from the worms using Sephasol^®^-RNA1 (Nacalai Tesque, Kyoto, Japan). Total RNA was used to synthesize cDNA using the PrimeScript™ RT Reagent Kit with gDNA Eraser (Takara Bio, Shiga, Japan). Primer sets were designed using GENETYX software (GENETYX Corporation, Tokyo, Japan) as follows: ornithine decarboxylase (*odc-1*), forward primer sequence, 5′-AAGGGCTCGGATTCAAGATGGA-3′, and reverse primer sequence, 5′-TTCAGCAATCAGGCGCTTGT-3′, *S*-adenosylmethionine decarboxylase (*smd-1*), forward primer sequence, 5′-ATGCGAGCCGGTATTGACAAG-3′, and reverse primer sequence, 5′-GGATGGTTGCGTATTGGTCAGT-3′, spermidine synthase (*spds-1*), forward primer sequence, 5′-AACGGGATGAGTTCTCCTACCA-3′, and reverse primer sequence, 5′-ACTCGTGCTTCAAGACCTCTCT-3′, human arginase type 1 erythroid. T21F4.1 was designed as follows: T21F4.1, forward primer sequence, 5′-CACGTGGGTGAGATAATATGCC-3′, and reverse primer sequence, 5′-CGTCGTCCGATACATTTCCTTC-3′, β-actin (*act-1* as an internal standard), forward primer sequence, 5′-TCCAAGAGAGGTATCCTTACCC-3′, and reverse primer sequence, 5′-CTCCATATCATCCCAGTTGGTG-3′. A CFX Connect^TM^ Real-Time System (Bio-Rad Laboratories, Inc. Hercules) with SYBR Premix Ex Taq (Takara Bio) was used to perform qPCR.

2.7. Lifespan Analysis {#sec2dot7-metabolites-09-00192}
----------------------

Control and B~12~-deficient worms were grown in ornithine (final concentration 10 μM)-, SAM (final concentration 1 μM)-, or Spd (final concentration 10 μM)-supplemented (final concentration 10 μM) medium for three days to evaluate the effects of ornithine, SAM, and Spd on the lifespan of *C. elegans*. Control worms, ornithine-supplemented control worms, Spd-supplemented control worms, B~12~-deficient worms, and Spd-supplemented B~12~-deficient worms were used as samples in this experiment. The lifespan of the worms was measured by the method of Apfeld and Kenyon \[[@B15-metabolites-09-00192]\]. Each worm was picked (approximately 10 animals per plate) and allowed to grow at 20 °C until they laid eggs. The next-generation worms (2- or 3-day-old) were picked to plates containing 5-fluoro-2′-deoxyuridine, which inhibits the worms from laying eggs. Worms were then tapped every 24 h and scored as dead when they did not move with repeated taps. The average lifespan of each worm was defined as a 50% survival rate obtained from the survival curves of each worm.

2.8. Protein Quantitation {#sec2dot8-metabolites-09-00192}
-------------------------

Protein quantification was determined by the Bradford method \[[@B16-metabolites-09-00192]\], with ovalbumin as the standard.

2.9. Statistical Analysis {#sec2dot9-metabolites-09-00192}
-------------------------

All data were evaluated by one-way ANOVA (non-parametric test), and a post-hoc analysis was performed using Tukey's multiple comparison tests. Analyses were performed with GraphPad Prism 3 for Windows version 2.01 (GraphPad Software Inc., La Jolla, CA, USA). All data are presented as the mean ± SEM. Differences were considered statistically significant at *p* \< 0.05.

3. Results {#sec3-metabolites-09-00192}
==========

3.1. Effect of B~12~ Deficiency on Free Amino Acids in C. elegans {#sec3dot1-metabolites-09-00192}
-----------------------------------------------------------------

[Table 1](#metabolites-09-00192-t001){ref-type="table"} shows the effect of B~12~ deficiency on free amino acids in *C. elegans*. Various amino acids (such as valine, leucine, and isoleucine) metabolized as part of the TCA cycle via the B~12~-dependent MCM pathway were increased significantly during B~12~ deficiency because MCM activity was significantly decreased during B~12~ deficiency \[[@B9-metabolites-09-00192]\]. Decreased MS activity induced a significant decrease in methionine, with a concomitant significant increase in cystathionine. In addition, threonine, lysine, aminoadipic acid, and ornithine levels were significantly increased during B~12~ deficiency. Significantly changed levels of such amino acids were mostly recovered to control levels when B~12~-deficient worms were grown for three generations under B~12~-supplemented conditions (recovery). These results indicate that B~12~ deficiency induces metabolic disorders of various amino acids in *C. elegans*. However, the accumulation of ornithine during B~12~ deficiency, to the best of our knowledge, is the first report.

3.2. Effects of B~12~ Deficiency on Arginase Activity and the Levels of mRNAs Encoding Putative Arginase in C. elegans {#sec3dot2-metabolites-09-00192}
----------------------------------------------------------------------------------------------------------------------

Ornithine is formed from arginine by the action of arginase involved in the urea cycle. However, *C. elegans* do not have an intact urea cycle. When we checked into the wormbase database, T21F4.1 \[[@B17-metabolites-09-00192]\] was registered as the orthologous gene human arginase type 1 and 2 erythroid variants in the wormbase database. Sequence analysis showed that *C. elegans* T21F4.1 has 27--35% and 68--73% of sequence identity and similarity, respectively, with *homo sapiens*, *Bacillus caldovelox*, *Bacillus subtilis*, and *Rattus norvegicus* arginases ([Figure 3](#metabolites-09-00192-f003){ref-type="fig"}).

To investigate the cause of ornithine accumulation caused by B~12~ deficiency, arginase activity was assayed. Worm arginase activity increased by approximately 1.7-fold in the B~12~-deficient worms compared with the control worms ([Figure 4](#metabolites-09-00192-f004){ref-type="fig"}a). The increased arginase activity in B~12~-deficient worms was recovered to control levels when the B~12~-deficient worms were grown under-recovery and NOHA-treated (a potent inhibitor of arginase) conditions. These results suggested that ornithine accumulated by the increased arginase activity observed during B~12~ deficiency.

The mRNA expression level of T21F4.1 was noted to exhibit the tendency to increase in the B~12~-deficient worms ([Figure 4](#metabolites-09-00192-f004){ref-type="fig"}c). However, this increased mRNA expression was not found to be significant. Nonetheless, T21F4.1 mRNA expression in B~12~-deficient worms was recovered to control levels when B~12~-deficient worms were grown under-recovery conditions. When B~12~-deficient worms were treated with NOHA, the addition of NOHA did not affect the mRNA expression level of T21F4.1, but did significantly decrease arginase activity, leading to decreased worm ornithine contents ([Figure 4](#metabolites-09-00192-f004){ref-type="fig"}a,b). These results suggested that B~12~ deficiency significantly increased arginase activity, which may be attributable to the mRNA expression of T21F4.1, leading to increased ornithine.

3.3. Effect of B~12~ Deficiency on Polyamine Levels of C. elegans {#sec3dot3-metabolites-09-00192}
-----------------------------------------------------------------

B~12~ deficiency showed that worm SAH increased significantly with a decrease in SAM ([Figure 5](#metabolites-09-00192-f005){ref-type="fig"}a,b). The SAM/SAH ratio as an index of the cellular methylation reaction was decreased to approximately 39% of the control levels ([Figure 5](#metabolites-09-00192-f005){ref-type="fig"}c). The decreased SAM/SAH ratio was completely recovered to control levels when B~12~-deficient worms were grown for three generations under B~12~-supplemented conditions. These results indicate that B~12~ deficiency leads to a disorder of cellular methylation reactions in *C. elegans* as well as in mammals.

As shown in [Figure 5](#metabolites-09-00192-f005){ref-type="fig"}a,b, B~12~ deficiency did not affect cellular Put but did significantly decrease Spd, which was approximately 83% of that in control worms. To clarify why Spd significantly decreased in *C. elegans* during B~12~ deficiency, the mRNA expression of enzymes involved in the biosynthesis of polyamines from ornithine was determined. Remarkably, the enzyme activity and mRNA expression levels of ODC ([Figure 6](#metabolites-09-00192-f006){ref-type="fig"}c,d) were increased in *C. elegans* during B~12~ deficiency. This did not affect the mRNA levels of Spd synthase (SPDS, *spds-1*), but did lead to significantly decreased SAM decarboxylase (SAMDC) (*smd-1*) mRNA levels ([Figure 6](#metabolites-09-00192-f006){ref-type="fig"}e,f). These altered mRNA levels were recovered to control levels when B~12~-deficient worms were grown for three generations under B~12~-supplemented conditions.

The addition of ornithine (10 μM) to control worms significantly increased ornithine levels up to approximately 0.58 μmol/g of worm, at which the ornithine levels were considered greater than those of B~12~-deficient worms. The added ornithine did not affect levels of Spd content, ODC activity, or *odc-1* and *smd-1* mRNA expression levels ([Figure 6](#metabolites-09-00192-f006){ref-type="fig"}b--e). However, these levels that were changed during B~12~ deficiency were mostly recovered to control levels in SAM (1 μM)-treated B~12~-deficient worms ([Figure 6](#metabolites-09-00192-f006){ref-type="fig"}b--e). These results suggested that the decreased Spd in B~12~-deficient worms was due to the reduction of SAM as a substrate for SAMDC.

3.4. Effect of Supplementation of Spd on the Lifespan of C. elegans {#sec3dot4-metabolites-09-00192}
-------------------------------------------------------------------

The maximal lifespan of B~12~-deficient worms was reduced to 22 days, compared with a lifespan of 28 days in control worms ([Figure 7](#metabolites-09-00192-f007){ref-type="fig"}). The average lifespan was decreased to a greater extent in B~12~-deficient worms (15.48 days) than in control worms (20.84 days). When B~12~-deficient worms were treated with Spd, the average lifespan (15.48 days) was extended to 17.42 days (an increase up to 1.94 days) ([Figure 7](#metabolites-09-00192-f007){ref-type="fig"}). In the case of control worms, the average lifespan of Spd-treated worms was 21.58 days (an increase of only 0.74 days). The addition of Spd to B~12~-deficient worms showed a significantly extended average lifespan, compared with that of B~12~-deficient worms. However, no significant difference was noted between the average lifespan of B~12~-deficient worms and Spd-treated B~12~-deficient worms, considering the extended average lifespan of Spd-supplemented control worms. These results indicated that the reduced lifespan of B~12~-deficient worms was recovered by approximately 22.4% through the addition of Spd, suggesting that the reduced lifespan of worms during B~12~ deficiency is partly caused by decreased Spd.

4. Discussion {#sec4-metabolites-09-00192}
=============

B~12~ deficiency reportedly disrupts the TCA cycle due to the decreased activity of succinate dehydrogenase \[[@B6-metabolites-09-00192]\], which is inhibited by MMA accumulation observed during B~12~ deficiency. This process then leads to significant increases in lysine and 2-aminoadipaic acid levels, with decreased formation of aspartic acid from oxaloacetic acid and glutamic acid through the actions of aspartate aminotransferase. Similarly, an increase was observed in the excretion of threonine, serine, valine, isoleucine, and lysine in urine in B~12~-deficient rats \[[@B5-metabolites-09-00192]\]. In addition, the mRNA and protein expression levels of hepatic serine dehydrogenase (a B~12~-independent enzyme), which catalyzes the conversion of serine and threonine to pyruvate and 2-oxobutyrate, respectively, were significantly lowered in B~12~-deficient rats \[[@B9-metabolites-09-00192]\]. However, the serine level was not found to be increased in B~12~-deficient worms.

Furthermore, we demonstrated for the first time, to the best of our knowledge, that B~12~ deficiency significantly increased the ornithine level, which is involved in polyamine biosynthesis \[[@B12-metabolites-09-00192]\]. The *E. coli* OP50 strain as the worm diet did not contain ornithine, and other amino acids showed no changes in *E. coli* cells grown in both B~12~-supplemented and B~12~-deficient conditions (data not shown). Ornithine is usually formed from arginine through the actions of arginase (EC 3.5.3.1), which is involved in the mammalian urea cycle \[[@B18-metabolites-09-00192]\]. However, *C. elegans* do not have an intact urea cycle because no homologous gene encoding enzymes involved in the urea cycle has been found in *C. elegans* (wormbase, wormbase.org, KEGG, [www.genome.jp/kegg](www.genome.jp/kegg)). Thus, *C. elegans* absolutely require arginine as an essential amino acid, as well as lysine, threonine, isoleucine, leucine, valine, methionine, phenylalanine, tryptophan, and histidine \[[@B10-metabolites-09-00192]\]. In particular, arginine reportedly functions as an energy-saving compound in *C. elegans* after being converted into arginine phosphate \[[@B10-metabolites-09-00192]\]. Arginine is not only metabolized by arginase to form ornithine and urea, but it is also metabolized by nitric oxide synthase (NOS) (EC 1. 14.13.39) to form nitric oxide (NO) and citrulline \[[@B19-metabolites-09-00192]\]. In this study, B~12~ deficiency did not affect arginine levels in *C. elegans* ([Table 1](#metabolites-09-00192-t001){ref-type="table"}), possibly to be able to sufficiently supply arginine from the diet. Although B~12~ deficiency reportedly increased cellular NO levels in *C. elegans* \[[@B20-metabolites-09-00192]\], a full complement of homologs of NOS has not yet been identified in the genome of *C. elegans*, suggesting that NO produced by bacteria (in the diet) in the worm gut may diffuse into the tissues. Our previous study \[[@B20-metabolites-09-00192]\] indicated that B~12~-deficiency in worms induces severe oxidative stress, which likely stimulates arginase activity because oxidative species reportedly increase arginase activity in bovine aortic endothelial cells \[[@B21-metabolites-09-00192]\].

Remarkably, urea, which is formed from arginine by arginase, has a tendency to increase in B~12~-deficient *C. elegans* ([Table 1](#metabolites-09-00192-t001){ref-type="table"}). Similarly, urea has been reportedly excreted in *C. elegans* \[[@B22-metabolites-09-00192]\] and the other free-living nematode, *Panagrellus redivivus* \[[@B23-metabolites-09-00192]\], implying the occurrence of arginase in *C. elegans*. These observations suggest that ornithine is enzymatically synthesized by arginase from arginine in *C. elegans* as an essential amino acid. The amino acid disorders observed in *C. elegans* during B~12~ deficiency are summarized in [Figure 8](#metabolites-09-00192-f008){ref-type="fig"}.

For measuring the arginase activity in *C. elegans*, some enzymatic properties of arginase were determined using a homogenate of B~12~-deficient worms ([Supplementary Figure S2](#app1-metabolites-09-00192){ref-type="app"}). Most arginases have the highest activity in alkaline pH ranges and require Mn(II) ion or Co(II) ion as a cofactor \[[@B24-metabolites-09-00192]\]. Similarly, arginase in the worms showed the highest activity at pH 8.0 and absolutely required Mn(II) ion. Even though arginase activity (approximately 0.4--0.8 pmol/min/mg protein) was detected in a homogenate of *C. elegans*, worm enzyme activity was significantly lower than that of human liver (5 μmol /min/mg protein) and red blood cells (0.05 μmol /min/mg protein) \[[@B25-metabolites-09-00192]\]. These results and perspectives indicated that *C. elegans* has the arginase with weak function. However, the gene product of T21F4.1 could not be characterized as arginase in detail because of the unsuccessful cloning and overexpression of the T21F4.1 gene. Peroxisome proliferator activated-receptor (PPAR) α is considered to possess the regulation function of the expression of genes involved in β-oxidation in fatty acids. Ahmad et al. \[[@B26-metabolites-09-00192]\] found that the protein expression of arginase 1 increases through the PPAR signaling pathway in B~12~-deficient rats. The mRNA level of T21F4.1 may increase due to the activation of PPAR signaling pathway by lipid metabolic disorder caused by B~12~ deficiency. When B~12~-deficient worms were grown in NOHA-treated conditions, ornithine was decreased to control level with a decrease in the arginase activity ([Figure 4](#metabolites-09-00192-f004){ref-type="fig"}a,b). These results suggested that the accumulation of ornithine during B~12~ deficiency was a result of the increase in arginase activity. In addition, urea is well-known as an antioxidant in the body \[[@B27-metabolites-09-00192]\]. Urea formed by the action of arginase may function as an antioxidant because B~12~ deficiency induced severe oxidative stress in *C. elegans*.

As described above, the increased arginase activity in *C. elegans* during B~12~ deficiency resulted in increased ornithine, which is a precursor amino acid of polyamines. The reduced activity of B~12~-dependent MS by B~12~ deficiency \[[@B8-metabolites-09-00192]\] further decreased cellular SAM levels ([Figure 5](#metabolites-09-00192-f005){ref-type="fig"}a), leading to a significant decrease of Spd ([Figure 6](#metabolites-09-00192-f006){ref-type="fig"}b) in *C. elegans.* A significant reduction in the cardiac and serum SAM/SAH ratio has been reported in mammals during B~12~ deficiency \[[@B28-metabolites-09-00192],[@B29-metabolites-09-00192]\] likewise B~12~-deficient worms. In addition, Spd reportedly stimulated B~12~-dependent MS activity \[[@B30-metabolites-09-00192]\], suggesting that reduced Spd may further decrease B~12~-dependent MS activity, thus increasing homocysteine \[[@B8-metabolites-09-00192]\] and leading to the further development of oxidative damage \[[@B20-metabolites-09-00192]\]. The biosynthesis of Put and Spd is highly regulated by two key enzymes, namely, ornithine decarboxylase (ODC, EC.4.1.1.17) and SAMDC (EC.4.1.1.50), are strongly regulated by feedback mechanisms at several levels, including transcriptional, translational, and post-translational \[[@B31-metabolites-09-00192]\]. In particular, ODC activity reportedly increased in murine L1210 leukemia cells \[[@B32-metabolites-09-00192]\] and in the spinal cords of totally gastrectomized rats \[[@B33-metabolites-09-00192]\] by the decrease in SAM. Spermine, which is a polyamine, was not detected in *C. elegans* in this study. *Caenorhabditis elegans* are not believed to contain spermine because no homologous gene of spermine synthase (EC. 2.5.1.22) has been found \[[@B34-metabolites-09-00192]\]. In general, *odc-1* and *smd-1* gene expressions were strictly regulated by substrates and productions \[[@B31-metabolites-09-00192]\]. From these results and suggestions, it was difficult to interpret the response of changes of odc-1 and smd-1 gene expression in the case of *C. elegans* not having spermine.

Polyamines play multiple roles in cell growth and death, including aging, neurodegenerative diseases, and metabolic disorders \[[@B35-metabolites-09-00192]\]. In particular, Spd has shown life-prolonging effects in various organisms, including in mammals and *C. elegans*. Indeed, Eisenberg et al. \[[@B36-metabolites-09-00192]\] have demonstrated that the administration of exogenous Spd significantly extends lifespan through epigenetic modifications, the inducement of autophagy, and a decline in necrosis using yeast, flies, *C. elegans*, and human immune cells as aging models. Remaining factors underlying the reduced lifespan observed during B~12~ deficiency may be due to inhibition of the TCA cycle, which would disrupt normal energy production, leading to oxidative damage in various cellular components, and reduced methylation reactions involving cellular compounds \[[@B8-metabolites-09-00192],[@B20-metabolites-09-00192]\].

5. Conclusions {#sec5-metabolites-09-00192}
==============

Collectively, our novel findings indicated that B~12~ deficiency induced both significant increases in ornithine and decreases in Spd, due to the reduction of SAM and/or the SAM/SAH ratio through decreased B~12~-dependent MS activity. Although such a phenomenon has not been reported in B~12~-deficient mammals, evidence exists that changes in polyamine levels are associated with aging and disease \[[@B37-metabolites-09-00192]\]. Thus, polyamines may prove to be key compounds underlying the symptoms of various health conditions (megaloblastic anemia, developmental disorders, growth retardation, and neuropathy) caused by B~12~ deficiency. To further clarify the accurate functions of polyamines associated with the symptoms of B~12~ deficiency in mammals, further studies are warranted.

The following are available online at <https://www.mdpi.com/2218-1989/9/9/192/s1>, Figure S1: HPLC analysis of polyamines (putrescine and spermidine) found in worms grown in vitamin B~12~-supplemented and vitamin B~12~-deficient conditions, Figure S2: Some properties of *Caenorhabditis elegans* arginase, Figure S3: Amino acid analysis of worms grown in vitamin B~12~-supplemented and vitamin B~12~-deficient conditions.

###### 

Click here for additional data file.
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![Outline of the amino acid analysis method.](metabolites-09-00192-g001){#metabolites-09-00192-f001}

![Scheme of derivatization of polyamines.](metabolites-09-00192-g002){#metabolites-09-00192-f002}

![Amino acid sequence alignments of arginases and putative arginase T21F4.1 in *C. elegans* using CLUSTAL W. Alignment of *C. elegans* T21F4.1 (accession no.NP_001257027.2) with *Bacillus caldovelox* arginase (accession no. S68863), *Bacillus subtilis* arginase (accession no. NP_391912.1), *Homo sapiens* arginase 1 (accession no. NP_001231367.1), *Rattus norvegicus* arginase 1 (accession no. NP_058830.2), *Homo sapiens* arginase 2 (accession no. NP_001163.1), and *Rattus norvegicus* arginase 2 (accession no. NP_062041.1). Highlighted areas indicate the amino acid signature motifs characteristic of the arginase family. Residues in bold are critical for the formation of a bimetallic cluster at the active-site. The analysis reveals that *C. elegans* T21F4.1 has 27--35% and 68--73% of sequence identity and similarity, respectively, with other arginases. The N- and C-terminal residues are omitted for clarity.](metabolites-09-00192-g003){#metabolites-09-00192-f003}

![Effects of vitamin B~12~ deficiency on arginase activity and the mRNA expression of the arginase orthologous gene, T21F4.1, in *C. elegans*. Arginase activity (**a**), ornithine contents (**b**), and mRNA expression levels of arginase orthologous gene, T21F4.1, (**c**) were determined in B~12~-deficient and control worms. After B~12~-deficient worms were grown for three generations under B~12~-supplemented conditions, these values were determined in the B~12~-treated worms (shown as "Recovery"). After B~12~-deficient worms were treated with N^ω^-hydroxy-L-arginine (NOHA) as a potent inhibitor of arginase, these values were determined (shown as "B~12~ deficiency + NOHA"). Data represent the mean ± SEM of three independent experiments. \* *p* \< 0.05 versus Control group. NS represents no significant differences.](metabolites-09-00192-g004){#metabolites-09-00192-f004}

![Effects of vitamin B~12~ deficiency on S-adenosylmethionine and S-adenosylhomocysteine contents of *C. elegans*. S-Adenosylmethionine (SAM, **a**) and S-adenosylhomocysteine (SAH, **b**) were determined in B~12~-deficient and control worms using HPLC, and then the SAM/SAH ratio (**c**) was calculated. After B~12~-deficient worms were grown for three generations under B~12~-supplemented conditions, these values were determined in the B~12~-treated worms (shown as "Recovery"). Data represent the mean ± SEM of three independent experiments. \* *p* \< 0.05 versus Control group. NS represents no significant differences.](metabolites-09-00192-g005){#metabolites-09-00192-f005}

![Effects of vitamin B~12~ deficiency on polyamine (putrescine and spermidine) levels and the mRNA expression levels of genes encoding enzymes involved in the biosynthetic pathway of spermidine from ornithine in *C. elegans*. Putrescine (**a**) and spermidine (**b**) levels and ornithine decarboxylase (ODC, **c**) activity were determined in control and B~12~-deficient worms using HPLC. Control worms and B~12~-deficient worms were grown in ornithine (final concentration 10 μM)-supplemented and S-adenosylmethionine (SAM) (final concentration 1 μM)-supplemented medium for three days. Ornithine-supplemented control worms and SAM-supplemented B~12~-deficient worms were also analyzed and shown as Control + Ornithine and B~12~ deficiency + SAM, respectively. The mRNA expression levels of the orthologous genes of human ODC (*odc-1*), spermidine synthase (*spds-1*), and S-adenosylmethionine decarboxylase (*smd-1*) represent (**d**), (**e**), and (**f**), respectively. Data represent the mean ± SEM of three independent experiments. \* *p* \< 0.05 versus Control group. NS represents no significant differences.](metabolites-09-00192-g006){#metabolites-09-00192-f006}

![Effect of spermidine on lifespan in control and B~12~-deficient worms. Control worms (◯), B~12~-deficient worms (△), control worms grown under the supplementation of spermidine (●), and B~12~-deficient worms grown under the supplementation of spermidine (▲). The gray-colored graphs represent control and B~12~-deficient worm data in this Figure. The lifespan of worms (mean days, *n* = number of worms scored) was measured as described in the text, control, 20.84 days, *n* = 126, B~12~ deficiency, 15.48 days, *n* = 113, spermidine-supplemented control, 21.58 days, *n* = 143, spermidine-supplemented B~12~ deficiency, 17.42 days, *n* = 106.](metabolites-09-00192-g007){#metabolites-09-00192-f007}

![Summary of the metabolic disorders of amino acids observed in *C. elegans* during vitamin B~12~ deficiency. MCM, methylmalonyl-CoA mutase, MS, methionine synthase, MMA, methylmalonic acid, SAM, S-adenosylmethionine, THF, tetrahydrofolate, 🡱, increase, 🡳, decrease.](metabolites-09-00192-g008){#metabolites-09-00192-f008}

metabolites-09-00192-t001_Table 1

###### 

Concentrations of free amino acids and other compounds in *C. elegans*.

                     *C. elegans* (mmol/g wet weight)                    
  ------------------ ---------------------------------- ---------------- -------------
  Amino acids                                                            
  Aspatic acid       1.29 ± 0.22                        0.58 ± 0.22      1.37 ± 0.29
  Threonine          0.55 ± 0.04                        0.80 ± 0.10 \*   0.49 ± 0.08
  Serine             0.76 ± 0.07                        0.93 ± 0.17      0.82 ± 0.08
  Asparagine         0.57 ± 0.07                        0.41 ± 0.07      0.61 ± 0.05
  Glutamic acid      3.27 ± 0.38                        3.41 ± 0.28      3.32 ± 0.45
  Glutamine          1.32 ± 0.22                        1.28 ± 0.29      1.27 ± 0.15
  Glycine            0.73 ± 0.06                        0.78 ± 0.05      0.63 ± 0.11
  Alanine            5.80 ± 0.66                        6.05 ± 0.22      5.53 ± 0.39
  Valine             0.58 ± 0.06                        1.03 ± 0.13 \*   0.52 ± 0.09
  Methionine         0.19 ± 0.03                        0.12 ± 0.03 \*   0.22 ± 0.04
  Isoleucine         0.37 ± 0.05                        0.61 ± 0.08 \*   0.36 ± 0.05
  Leucine            0.70 ± 0.09                        1.07 ± 0.12 \*   0.63 ± 0.10
  Tyrosine           0.22 ± 0.02                        0.30 ± 0.02      0.24 ± 0.04
  Phenylalanine      0.35 ± 0.05                        0.47 ± 0.10      0.40 ± 0.06
  Ornithine          0.21 ± 0.07                        0.43 ± 0.05 \*   0.29 ± 0.10
  Lysine             0.43 ± 0.04                        0.71 ± 0.01 \*   0.40 ± 0.04
  Histidine          0.34 ± 0.04                        0.55 ± 0.12      0.39 ± 0.05
  Arginine           0.88 ± 0.10                        1.14 ± 0.16      0.81 ± 0.05
  Hydroxyproline     0.07 ± 0.06                        0.03 ± 0.01      0.05 ± 0.03
  Others                                                                 
  Cystathionine      0.57 ± 0.06                        3.57 ± 0.31 \*   0.78 ± 0.13
  Aminoadipic acid   0.79 ± 0.09                        1.44 ± 0.12 \*   0.92 ± 0.15
  Urea               1.66 ± 0.52                        2.44 ± 0.90      1.84 ± 0.66

Results are presented as means ± SEM (*n* = 5). Values with asterisk (\*) is significantly different (*p* \< 0.05).
